# Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

> **NCT00083070** · PHASE1 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 16 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00083070
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2004-09
- **Final completion:** 2008-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00083070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00083070, "Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00083070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*